News Item
Life Science Greenhouse of Central PA (LSGPA) invests in QuantumBio for accelerating drug discovery efforts using unique molecular modeling tools
June 23, 2005

About QuantumBio, Inc.
QuantumBio's software suite of quantum
mechanically-based molecular modeling tools and
unique database of protein structures critical to
drug discovery are based on technology developed
between 1995 and the present at Penn State University
(PSU) in the labs of Dr. Kenneth Merz, an
international leader in the field of computational
chemistry for drug discovery. These proprietary tools
will enable scientists engaged in drug discovery to
leverage the precision of quantum mechanical
approaches to model interactions between proteins and
small molecules far better than the classical
mechanics-based software models currently available
on the market. In addition, the company is expected
to benefit from an expanding list of technology
emerging from PSU in the form of provisional patents
and invention disclosures.